Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).

Shinichi KomiyamaKazuyoshi KatoYuki InokuchiHirokuni TakanoTakashi MatsumotoAtsushi HongoMikiko Asai-SatoAtsushi ArakawaShoji KamiuraTsutomu TabataNobuhiro TakeshimaToru Sugiyama

Published in: International journal of clinical oncology (2018)

Combining bevacizumab with chemotherapy was tolerable and efficacy was acceptable in Japanese patients with advanced epithelial ovarian cancer. Bevacizumab seems to reduce platinum-resistant recurrence and is promising for clear cell carcinoma.

Keyphrases

metastatic colorectal cancer
locally advanced
clinical trial
study protocol
phase iii
rectal cancer
radiation therapy
metastatic breast cancer
open label